Participating Groups or Countries
One principal investigator will be designed within each country or group and will correspond with the sponsor regarding the organization of the trial.
| Country | Study Group / Centers | Principal Investigator | Study Participation |
|---|---|---|---|
| Scandinavia | NLG | Prof. F. d'Amore Francesco.damore@as.aaa.dk |
ACT-1 + ACT-2 |
| Germany | DSHNHL | Prof. L. Trümper E-Mail-Adresse |
ACT-2 |
| Frankfurt | Dr Weidmann E-Mail-Adresse |
ACT-1 + ACT-2 | |
| Netherlands | EORTC | Prof. H. Kluin-Nelemans E-Mail-Adresse |
ACT-1 + ACT-2 |
| HOVON | Dr. G. van Imhoff E-Mail-Adresse |
ACT-1 + ACT-2 | |
| France | GELA | Prof. C. Gisselbrecht E-Mail-Adresse |
ACT-2 |
| GOELAMS | Dr. O. Tournilhac E-Mail-Adresse |
ACT-2 | |
| Belgium | GELA, EORTC, HOVON | Dr. E. Van den Neste E-Mail-Adresse |
ACT-1 + ACT-2 |
| Spain | GELTAMO | Dr. J. Rodriguez E-Mail-Adresse |
ACT-1 + ACT-2 |
| Italy | IIL | Prof. P.L. Zinzani E-Mail-Adresse |
ACT-1 + ACT-2 |
| UK | NCRI | Prof. R. Pettengell E-Mail-Adresse |
ACT-1 + ACT-2 |
| Austria | Vienna | Prof. G. Hopfinger E-Mail-Adresse |
ACT-1 + ACT-2 |
| Portugal | Lissabon and Porto | Prof. M. G. Silva E-Mail-Adresse |
ACT-1 + ACT-2 |
| Poland | Polish Lymphoma Group | Prof. J Walewsky E-Mail-Adresse |
ACT-1 + ACT-2 |
| Russia | Russian Lymphoma Group | Prof. I. Poddubnaya E-Mail-Adresse |
ACT-1 + ACT-2 |
| Israel | Tel Aviv | Prof. O. Shpielberg E-Mail-Adresse |
ACT-1 + ACT-2 |
| Australia | ALLG | Prof. J. Seymour E-Mail-Adresse |
ACT-1 + ACT-2 |
| Serbia | Serbian Lymphoma Group | Dr. B. Mihaljevic E-Mail-Adresse |
ACT-1 + ACT-2 |
| Czech Republic | Czech Lymphoma Group | Prof. M. Trneny E-Mail-Adresse |
ACT-1 + ACT-2 |
| Slovakia | Bratislava | Prof. A. Vranovsky E-Mail-Adresse |
ACT-1 + ACT-2 |
Navigation
Clinical Trials & Study Groups
Foerderer, Partner und Zertifikate
,
